P031 Impact of the elexacaftor/tezacaftor/ivacaftor combination regimen on lung function in adults with cystic fibrosis: more than just FEV1
| Autor: | Wollsching-Strobel, M., Dieninghoff, D., Emrich, L.F., Kroppen, D., Majorski, D.S., Mathes, T., Magnet, F.S., Schwarz, S.B., Crieé, C.-P., Windisch, W. |
|---|---|
| Zdroj: | In Journal of Cystic Fibrosis June 2022 21 Supplement 1:S69-S69 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect